Black Rock Inc. Nanobiotix S.A. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Nanobiotix S.A. stock. As of the latest transaction made, Black Rock Inc. holds 239,008 shares of NBTX stock, worth $853,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239,008
Previous 253,454
5.7%
Holding current value
$853,258
Previous $1.65 Million
27.44%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NBTX
# of Institutions
18Shares Held
6.25MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$20.1 Million5.5% of portfolio
-
Perceptive Advisors LLC New York, NY266KShares$949,9520.03% of portfolio
-
Old Mission Capital LLC48.5KShares$173,0520.0% of portfolio
-
Jane Street Group, LLC New York, NY23.3KShares$83,1200.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny13.5KShares$48,0230.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $125M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...